Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000223043 | SCV000272794 | uncertain significance | not specified | 2015-10-22 | criteria provided, single submitter | clinical testing | The p.Val27749Ala variant in TTN has not been previously reported in individuals with cardiomyopathy but has been identified in 2/11568 Latino chromosomes and 1 /9802 African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac .broadinstitute.org). Computational prediction tools and conservation analysis d o not provide strong support for or against an impact to the protein. In summary , the clinical significance of the p.Val27749Ala variant is uncertain. |
Athena Diagnostics | RCV000223043 | SCV000616172 | uncertain significance | not specified | 2017-05-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001569293 | SCV001793339 | likely benign | not provided | 2019-11-14 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001569293 | SCV003824169 | uncertain significance | not provided | 2023-12-21 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001569293 | SCV001978869 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001569293 | SCV001979795 | uncertain significance | not provided | no assertion criteria provided | clinical testing |